Simlow Cancer Hospitalat Yale-New Haven — New Haven, Connecticut

Simlow Cancer Hospitalat Yale-New Haven is a clinical research site located in New Haven, Connecticut, United States 06510.

Crixeo Clinical Trials Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

Simlow Cancer Hospitalat Yale-New Haven has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Exocrine Pancreatic Cancer.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in New Haven

Browse all research sites in Connecticut · View every site in New Haven

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Simlow Cancer Hospitalat Yale-New Haven?

Simlow Cancer Hospitalat Yale-New Haven has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Simlow Cancer Hospitalat Yale-New Haven conducted?

Simlow Cancer Hospitalat Yale-New Haven has 1 clinical trials on record, with 1 currently active. Their work covers Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Exocrine Pancreatic Cancer.

Is Simlow Cancer Hospitalat Yale-New Haven accredited by Crixeo Clinical Trials?

Simlow Cancer Hospitalat Yale-New Haven has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Simlow Cancer Hospitalat Yale-New Haven?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.